NCT02973672 - Phase I of SGM-101 in Patients With Cancer of the Colon, Rectum or Pancreas | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

April 15, 2019

Study Completion Date

May 31, 2019

Conditions

Colon CancerRectum CancerPancreas CancerMetastatic Colorectal CancerRecurrent Colorectal Carcinoma

Interventions

DRUG

SGM-101

4 days before surgery, SGM-101 will be administered to the patient by intravenous injections.

Trial Locations (3)

Catharina Ziekenhuis Eindhoven, Eindhoven

Erasmus Medical Center Cancer Institute, Rotterdam

Leiden University Medical Center, Leiden